GROWING NEED FOR BIOANALYTICAL SERVICES BY CLIENTS RESULTS IN SECOND LABORATORY EXPANSION IN TWO YEARS FOR SMITHERS AVANZA
Smithers Avanza is a contract research organization (CRO) supporting the pharmaceutical industry, whose Scientists have expertise in large molecule bioanalysis, assay development, validation and sample analysis at their GLP- and GCP-compliant and CLIA certified laboratory. Smithers Avanza Bioanalytical Services Division supports the development of biologics and vaccines from discovery through phase IV, with expertise that includes bioassays and high sensitivity assays. Smithers Avanza also offers preclinical toxicology and vaccine testing at their AAALAC accredited facilities.
New Space & Increased Capacity Will Support Client Requests for Testing of Large Molecule Biotherapeutics –
Smithers Avanza, announced that its Bioanalytical Services Division has completed the second expansion of its bioanalytical laboratory in the last two years. The expansion doubles the size of the Gaithersburg, Maryland lab, which now offers 15,000 square feet of space, and continues the trend of growth in support of client demand for services.
Smithers Avanza celebrated the completed expansion and the renewal of their commitment to doing business in Maryland with clients, employees, state and local officials and community friends with an Open House on Wednesday, May 17, 2017.
Ira S DuBey, Executive Vice President, Bioanalytical Services
Phyllis Conliffe, Executive Director, Bioanalytical Services
“We are very fortunate to count some of the world’s leading biopharmaceutical companies as our clients and friends,” said Ira DuBey, Executive Vice President, Bioanalytical Services Division, Smithers Avanza. “Through these relationships, we are given an opportunity to grow in order to be the best possible partner, which often involves a need for additional space, staff and new equipment to meet an increasing volume of projects.”
Following the expansion, the company has already added several new staff members, including senior scientific and support personnel. These new staffers will allow Smithers Avanza to continue to support client development of large molecule biologics including immuno-oncology drugs and combination therapies. Further, the company acquired new liquid handling robotics instrumentation and another Singulex instrument. This equipment will help meet the growing need for testing of high sensitivity biomarker and pharmacokinetic assays.
As part of the expansion, the company is augmenting its lab’s capabilities through new instruments such as the recently added Gyros GyroLab xPS workstation as well as the Simoa HD-1 Analyzer from Quanterix.
Smithers Avanza has been an active member of the Maryland Tech Council for over 10 years.
For more information about the Smithers Avanza portfolio of services, visit www.smithersavanza.com or contact Hope Aubin, 508-295-2550 haubin@smithers.com